ClinicalTrials.Veeva

Menu

Reliability and Validity Study of the Turkish Version of the Parkinson's Disease Dyskinesia Scale (PDYS-26)

I

Izmir Bakircay University

Status

Enrolling

Conditions

Idiopathic Parkinson Disease
Quality of Life
Dyskinesias

Treatments

Other: Turkish version of the Parkinson's Disease Dyskinesia Scale (PDYS-26)

Study type

Observational

Funder types

Other

Identifiers

NCT07023224
IZBU-FTR-ITB-01

Details and patient eligibility

About

The aim of this methodological study was to investigate the Turkish validity and reliability of the Parkinson's Disease Dyskinesia Scale (PDYS-26).The scale evaluates choreic dyskinesia.Measures the impact of dyskinesia on activities of daily living in patients with Parkinson's disease.

Hypotheses of the Study:

  • Parkinson's Disease Dyskinesia Scale (PDYS-26) is reliable in Turkish.
  • Parkinson's Disease Dyskinesia Scale (PDYS-26) is valid in Turkish.

To determine the validity of dyskinesia;

  • Tampa Kinesiophobia Scale,
  • Mini BesTest,
  • Activity Specific Balance Safety Scale (ABC) and
  • Parkinson's Disease Questionnaire-39 will be evaluated.

Full description

In Parkinson's disease, a neurodegenerative disorder affecting the peripheral and central nervous system, dyskinesia is a common symptom that occurs as disease processes progress and leads to disability. The term dyskinesia is a general term that covers many movement disorders. In general, it can be defined as mild to severe abnormal and involuntary muscle movements. In individuals with Parkinson's disease, it is a natural consequence of the neurodegenerative process and a motor complication of the gold standard L-dopa. Assessment of dyskinesia in Parkinson's patients is important for the implementation of appropriate medical, surgical and rehabilitation protocols. There are few scales and patient diaries that clinically assess the effect of interventions for dyskinesia. At the same time, there are deficiencies related to the reliability and validity studies of these existing scales in different languages. Therefore, limitations may arise in the assessment of dyskinesia. For this purpose, our study aims to investigate the reliability and validity of the Parkinson's Disease Dyskinesia Scale (PDYS-26) in Turkish in patients diagnosed with 130 idiopathic Parkinson's patients.In the study, the Parkinson's Disease Dyskinesia Scale (PDYS-26) will be translated into Turkish with the "back translation" method and will be finalized after the approval of the commission consisting of relevant health professionals. The final version of the scale will be applied to Parkinson's patients. To determine the validity of dyskinesia; Tampa Kinesiophobia Scale, Mini BesTest Activity Specific Balance Safety Scale (ABC) and Parkinson's Disease Questionnaire-39 will be evaluated.

Enrollment

130 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Being diagnosed with idiopathic Parkinson's disease
  • H&Y stage 1-3
  • UPDRS dyskinesia item score ≥1
  • Accepting to participate in the study

Exclusion criteria

  • Diagnosis of atypical-secondary parkinsonism
  • Severe musculoskeletal, neurological and/or cardiopulmonary problems that may affect the results of the assessment
  • Mini Mental State Examination score < 24

Trial design

130 participants in 1 patient group

Parkinson Patients with Dyskinesia
Description:
Parkinson's disease patients with a Unified Parkinson's Disease Rating Scale (UPDRS) dyskinesia score of ≥1. Participants must meet the inclusion criteria and provide informed consent.
Treatment:
Other: Turkish version of the Parkinson's Disease Dyskinesia Scale (PDYS-26)

Trial contacts and locations

2

Loading...

Central trial contact

Irem Tepe Bark, PT; Gulbin Ergin, PT, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems